Apr
29
TPVH 3rd Negotiations meeting, 29 April 2024
Brussels Belgium
TPVH 3rd Negotiations meeting, 29 April 2024
Health and Social Services, Health and Safety, Trade, Gender pay gap
Date
Mar. 19, 2024
A new WHO Report published on 12 March echoes EPSU recommendations on gender and care
The report, Fair share for health and care: gender and the undervaluation of health and care work details gender value gaps and demonstrates how health and care work is globally undervalued, why this is a gender equality issue, and what can be done about it.
Mar. 19, 2024
Social partners take action against third-party violence and harassment at work
An unprecedented number of European sectoral trade unions and employers launched negotiations on third-party violence and harassment at work on Tuesday, 19 March 2024, with the support of the European Commission.
Mar. 07, 2024
Labour shortages: Social Partners jointly respond to the European Commission Consultation on Labour and Skills Shortages in the EU: An Action Plan
In a coordinated action, EPSU joined with Social Partners in Health and Social Services to responded to the European Commission consultation on Labour and Skills Shortages in the EU Action Plan.
Feb. 07, 2024
EPSU and HOSPEEM presented their policy on stress at work at the high-level Belgian Presidency conference
EPSU and HOSPEEM in the capacity of social partners in the hospital and healthcare sector were invited by the Belgian Presidency to participate in the conference dedicated to mental health and work.
Oct. 17, 2023
Staff shortages, mental health and social dialogue discussed by health and social care trade unions
45 participants, including external speakers, discussed developments in the health and care sector taking place since the previous meeting in February of this year, including the urgent issue of staff shortages, retention and recruitment.
Sep. 19, 2023
EPSU expert group discusses Occupational Safety and Health in HSS
The group discussed recent developments on worker protection in the EU and beyond, an interactive risk assessment tool in healthcare, and the revisions of directives on Carcinogens and Mutagens and Reprotoxins (CMRD 5) and asbestos.
